Cleared Traditional

K222850 - HAVAb IgG II

K222850 is an FDA 510(k) clearance for HAVAb IgG II, manufactured by Abbott Laboratories. The device is a Class 2 Microbiology device with product code LOL cleared through the Traditional 510(k) pathway after a 323-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2023
Decision
323d
Days
Class 2
Risk

K222850 is an FDA 510(k) clearance for the HAVAb IgG II. Classified as Hepatitis A Test (antibody And Igm Antibody) (product code LOL), Class II - Special Controls.

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on August 10, 2023 after a review of 323 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3310 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Abbott Laboratories devices

FDA 510(k) Submission Details - K222850

510(k) Number K222850 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 21, 2022
Decision Date August 10, 2023
Days to Decision 323 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
221d slower than avg
Panel avg: 102d · This submission: 323d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LOL Device Classification - Class 2, Special Controls

Product Code LOL Hepatitis A Test (antibody And Igm Antibody)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3310
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - LOL Hepatitis A Test (antibody And Igm Antibody)

All 24
Devices cleared under the same product code (LOL) and FDA review panel - the closest regulatory comparables to K222850.
Elecsys Anti-HAV IgM
K260048 · Roche Diagnostics · Apr 2026
Access anti-HAV IgM
K251995 · Beckman Coulter, Inc. · Jan 2026
Access anti-HAV
K243846 · Beckman Coulter, Inc. · Sep 2025
LIAISON Anti-HAV
K223403 · DiaSorin, Inc. · Dec 2022
LIAISON Anti-HAV
K210272 · DiaSorin, Inc. · Feb 2021
LIAISON Anti-HAV Assay
K193532 · DiaSorin, Inc. · Mar 2020